FdaApplication

NDA 204671

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGILEAD SCIENCES INC
application_typeNDA
approval_date2013-12-06

Products (2)

ProductActive ingredientStrengthDosage form
SOVALDISOFOSBUVIR200MGTABLET;ORAL
SOVALDISOFOSBUVIR400MGTABLET;ORAL

2 products